Construction work has begun to build the VaxThera plant, which will produce vaccines and biologicals for Colombia and the region

Rionegro, February 02, 2022 – After more than 20 years without vaccines or biologicals being produced in the country, VaxThera, a Colombian company specializing in   biotechnology, began construction of its manufacturing plant in Rionegro, Antioquia.  Colombia will once again be in control of its own healthcare systems. Thanks to the investment of 54 million dollars by […]

Independence of Biologicals for Colombia: Why is it historically important?

Medellín, July 2022. Within the framework of Colombian Independence Day, the country is celebrating the first anniversary of VaxThera, a Colombian company owned by Seguros SURA, that is an expert on biotechnology, and will contribute to the country’s and the region’s independence in terms of vaccines and biologicals. No vaccines have been produced in Colombia […]

Seguros SURA took second place in ANDI’s innovation ranking, highlighting VaxThera as its biggest innovation during the past year

August 16, 2022. Colombia’s National Association of Industrialists (Asociación Nacional de Empresarios – ANDI) each year recognizes the efforts, work, and results in the area of innovation in the private sector and does this through its Business Innovation Ranking. In its sixth edition, SURA took second place as the country’s most innovative company, climbing eight […]

Innovation in the health sector

By: Leonor HidalgoDirector of Trust Relations and SustainabilityVaxThera October 18, 2022. This October, INNOS—the Institute for Foresight and Innovation in Health, a joint initiative between Afidro (the Association of Research-Based Pharmaceutical Laboratories) and the Universidad del Bosque—published the Panorama of Health Innovation in Colombia (PINNOS). To provide some context, I would like to quote from […]